PAPOLA
Basic information
Region (hg38): 14:96501433-96567116
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAPOLA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 26 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 3 | 3 |
Variants in PAPOLA
This is a list of pathogenic ClinVar variants found in the PAPOLA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-96502607-A-C | Benign (Mar 29, 2018) | |||
14-96520119-C-G | not specified | Uncertain significance (Feb 28, 2023) | ||
14-96520155-G-C | not specified | Likely benign (Aug 02, 2022) | ||
14-96521023-A-G | not specified | Uncertain significance (Sep 27, 2024) | ||
14-96521071-A-G | not specified | Uncertain significance (Oct 14, 2023) | ||
14-96527475-G-A | not specified | Uncertain significance (Jul 09, 2024) | ||
14-96531537-T-C | Benign (Dec 31, 2019) | |||
14-96532402-A-G | not specified | Uncertain significance (Mar 10, 2025) | ||
14-96532514-A-G | not specified | Uncertain significance (Dec 24, 2024) | ||
14-96532550-G-A | not specified | Uncertain significance (Dec 31, 2024) | ||
14-96532628-T-G | not specified | Uncertain significance (Jun 07, 2024) | ||
14-96532645-A-C | not specified | Uncertain significance (Nov 10, 2024) | ||
14-96535884-C-A | not specified | Uncertain significance (Dec 28, 2023) | ||
14-96535912-A-G | not specified | Uncertain significance (Jan 17, 2025) | ||
14-96542287-G-A | not specified | Uncertain significance (Jan 21, 2025) | ||
14-96542776-T-A | not specified | Uncertain significance (Sep 20, 2024) | ||
14-96542870-A-G | not specified | Likely benign (Oct 12, 2024) | ||
14-96542875-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
14-96544232-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
14-96547861-A-G | Uncertain significance (-) | |||
14-96552493-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
14-96552499-A-G | not specified | Likely benign (Nov 19, 2022) | ||
14-96552527-C-T | Benign (Mar 29, 2018) | |||
14-96552537-A-G | not specified | Uncertain significance (Jul 14, 2023) | ||
14-96552559-C-T | not specified | Uncertain significance (Nov 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PAPOLA | protein_coding | protein_coding | ENST00000216277 | 22 | 65679 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000196 | 125724 | 0 | 5 | 125729 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.55 | 190 | 386 | 0.492 | 0.0000188 | 4875 |
Missense in Polyphen | 15 | 103.08 | 0.14552 | 1363 | ||
Synonymous | 0.438 | 130 | 137 | 0.952 | 0.00000709 | 1436 |
Loss of Function | 5.71 | 3 | 43.8 | 0.0686 | 0.00000220 | 525 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000882 | 0.0000882 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus. {ECO:0000269|PubMed:19224921}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);mRNA Processing;Gene expression (Transcription);polyadenylation of mrna;RNA Polymerase II Transcription;Metabolism of RNA;Processing of Intronless Pre-mRNAs;Processing of Capped Intronless Pre-mRNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;Purine metabolism;mRNA Splicing - Major Pathway;TNFalpha;mRNA Splicing;mRNA 3,-end processing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.121
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.910
- hipred
- Y
- hipred_score
- 0.785
- ghis
- 0.680
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.903
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Papola
- Phenotype
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA polyadenylation;mRNA 3'-end processing;regulation of mRNA 3'-end processing;RNA polyadenylation
- Cellular component
- nucleus;nucleoplasm;cytoplasm
- Molecular function
- magnesium ion binding;RNA binding;polynucleotide adenylyltransferase activity;protein binding;ATP binding;manganese ion binding